EOLPodcast

Ep. 295 Psilocybin Therapy at End of Life: The Legal Case with Kathryn Tucker, JD

Learn about the legal effort to make psilocybin available as a transformative therapy at the end of life.

My guest Kathryn Tucker is a Special Counsel at Emerge Law Group where she co-chairs the Psychedelic Practice Group. She is also the Executive Director of the End-of-Life Liberty Project and served two decades as Director of Advocacy and Legal Affairs for Compassion & Choices, working to improve care and expand choice at the end of life. She shares the current legal case she is spearheading to allow terminally ill patients to try psilocybin as a palliative care medication and how psilocybin has already been shown to be hugely beneficial to patients at the end of life. Learn more about her work at:

www.emergelawgroup.com

Listen here:

This episode includes:

  • The benefits of psilocybin therapy for palliative care
  • Why terminally ill patients cannot currently access psilocybin therapy
  • What are Right to Try (RTT) laws and how they may apply to psilocybin
  • History behind psilocybin being labeled a Schedule I drug by the DEA
  • Test case that has been filed in court based on Washington state and Federal RTT laws
  • How “friends of the court” can be helpful to this case
  • Why the success of this case could open access for patients in other states
  • Oregon’s Psilocybin Therapy Law and implications for other states

Links mentioned in this episode:

If you enjoy this content please share it with others and consider leaving a review on iTunes! Thanks again to all supporters on my page at Patreon.com/eolu! Your contributions make all the difference!

EOLPodcast

Ep. 273 The Benefits of Psychedelics for End-of-Life Patients with Ira Byock MD

Learn about new research using psychedelic medications to help patients at the end of life with depression and anxiety.

My guest Dr. Ira Byock is a leading palliative care physician, author and public advocate for improving care through the end of life. In this discussion he shares important information about psychedelic medications and the benefits they offer to patients at the end of life. There is current research available that shows the value of these medications especially for patients with depression, anxiety and loss of meaning who experience a profound reframing of life. Learn more about Dr. Byock’s work at his website:

www.irabyock.org

Listen here:

This episode includes:

  • How Dr. Byock got interested in studying psychedelic medications for palliative and hospice patients
  • What new research is revealing about the benefits of psychedelics for various medical conditions
  • How psychedelics have been shown to be helpful with depression, anxiety and demoralization syndrome
  • The dangers of recreational use of psychedelics vs. controlled therapeutic use
  • What a “psychedelic assisted therapeutic experience” consists of
  • How a psychedelic experience can rewrite the brain’s “default mode network”
  • The need for further research on these medications

Links mentioned in this episode:

  • Subscribe to this podcast on AppleGoogleSpotifyiHeart RadioStitcher Radio
  • Check out the Series I’ve recorded in the past here
  • Join the team at Patreon.com/eolu and get access to the EOLU mug“Mind if we talk about death?” (only Patrons can purchase it). PLUS get our new bonuses: the monthly EOL News Update, movie reviews from 2 Doctors and a Movie, and automatic access to A Year of Reading Dangerously!

If you enjoy this content please share it with others and consider leaving a review on iTunes! Thanks again to all supporters on my page at Patreon.com/eolu! Your contributions make all the difference!